Technical Analysis for CXRXF - ADVANZ PHARMA Corp.

Grade Last Price % Change Price Change
grade F 9.4 -3.39% -0.3300
CXRXF closed down 3.39 percent on Friday, August 23, 2019, on 3.69 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical CXRXF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for CXRXF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ADVANZ PHARMA Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia International Corp. and changed its name to ADVANZ PHARMA Corp. in November 2018. ADVANZ PHARMA Corp. is headquartered in Mississauga, Canada.
Medicine Health RTT Cancer Pharmaceutical Industry Clinical Medicine Pharmaceutical Laser Arthritis Cancer Treatments Epilepsy Malaria Urinary Tract Infections Irritable Bowel Syndrome Laser Medicine Light Therapy Lupus Photodynamic Therapy Adjunctive Therapy Cystitis Bacterial Infection Bladder Infections Generic Prescription Products Levothyroxine Partial Seizures Porfimer Sodium Therapy For Irritable Bowel Syndrome Treatment Of Certain Forms Of Cancer
Is CXRXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 68.4
52 Week Low 9.32
Average Volume 704
200-Day Moving Average 0.0
50-Day Moving Average 15.0111
20-Day Moving Average 13.3655
10-Day Moving Average 11.6027
Average True Range 0.7049
ADX 23.78
+DI 22.7479
-DI 54.6168
Chandelier Exit (Long, 3 ATRs ) 15.6153
Chandelier Exit (Short, 3 ATRs ) 11.4347
Upper Bollinger Band 17.7549
Lower Bollinger Band 8.9761
Percent B (%b) 0.05
BandWidth 65.682541
MACD Line -1.5415
MACD Signal Line -1.1127
MACD Histogram -0.4288
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.7615
Resistance 3 (R3) 9.7750 9.6680 9.7013
Resistance 2 (R2) 9.6680 9.5759 9.6613 9.6812
Resistance 1 (R1) 9.5340 9.5191 9.4805 9.5205 9.6611
Pivot Point 9.4270 9.4270 9.4003 9.4203 9.4270
Support 1 (S1) 9.2930 9.3349 9.2395 9.2795 9.1389
Support 2 (S2) 9.1860 9.2781 9.1793 9.1188
Support 3 (S3) 9.0520 9.1860 9.0988
Support 4 (S4) 9.0385